Agios Pharmaceuticals logo
Agios Pharmaceuticals AGIO
$ 55.81 2.18%

Quarterly report 2024-Q3
added 10-31-2024

report update icon

Agios Pharmaceuticals Balance Sheet 2011-2024 | AGIO

Annual Balance Sheet Agios Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-16.2 M -53.6 M -192 M -127 M 32.7 M -70.5 M -103 M -161 M -71.8 M -14 M -71.6 M -91.3 M -118 M

Long Term Debt

57 M 72 M 276 K 164 K - - - - - - - - -

Long Term Debt Current

15 M 13.7 M 10.8 M 7.09 M 6.64 M - - - - - - - -

Total Non Current Liabilities

- - - - 157 M 77.4 M 144 M 172 M 22.1 M 6.45 M 32.8 M 58 M 83.2 M

Total Current Liabilities

68 M 62.6 M 59.8 M 94.4 M 92.9 M 93.5 M 94.9 M 88.4 M 52.9 M 61.1 M 36.9 M - -

Total Liabilities

126 M 138 M 146 M 453 M 250 M 171 M 239 M 261 M 74.9 M 67.5 M 69.7 M 93.1 M 131 M

Deferred Revenue

- - - - 10.9 M 32.7 M 37.8 M 35.9 M 19.7 M 35.7 M 25.1 M 25.1 M 25.1 M

Retained Earnings

-823 M -471 M -239 M -1.84 B -1.52 B -1.1 B -798 M -483 M -285 M -167 M -113 M -74 M -53.9 M

Total Assets

937 M 1.24 B 1.44 B 853 M 891 M 858 M 614 M 619 M 420 M 492 M 201 M 137 M 194 M

Cash and Cash Equivalents

88.2 M 139 M 203 M 127 M 80.9 M 70.5 M 103 M 161 M 71.8 M 14 M 71.6 M 91.3 M 118 M

Book Value

811 M 1.1 B 1.29 B 400 M 641 M 688 M 376 M 359 M 345 M 424 M 131 M 43.9 M 63.1 M

Total Shareholders Equity

811 M 1.1 B 1.29 B 400 M 641 M 688 M 376 M 359 M 345 M 424 M 131 M -72 M -52.8 M

All numbers in USD currency

Quarterly Balance Sheet Agios Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

44.5 M 48.8 M 52.9 M 57 M 60.8 M 64.6 M 68.3 M 72 M 75.5 M - 276 K 85.7 M - 167 K 248 K 331 K 331 K 331 K 331 K 673 K 673 K 106 M 106 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

165 M 113 M 106 M 126 M 120 M 121 M 115 M 138 M 130 M - 128 M 146 M 147 M 153 M 192 M 453 M 453 M 453 M 453 M 250 M 250 M 250 M 250 M 171 M 171 M 171 M 171 M 239 M 239 M 239 M 239 M 261 M 261 M 261 M - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - 2.5 M - - - - - - - 4.75 M 10.9 M 10.9 M 10.9 M 10.9 M 32.7 M 32.7 M 41.1 M 39.2 M 37.8 M 35.9 M 37.1 M 37.8 M 35.9 M 35.9 M 35.9 M 35.9 M 19.7 M 19.7 M 19.7 M 19.7 M 35.7 M 35.7 M 35.7 M 35.7 M 25.1 M 25.1 M 25.1 M 25.1 M 25.1 M 25.1 M 25.1 M - - - - -

Retained Earnings

-52.4 M -1 B -904 M -823 M -727 M -635 M -552 M -471 M -507 M - -334 M -239 M -144 M -55.4 M 30.8 M -1.84 B -1.84 B -1.84 B -1.84 B -1.52 B -1.52 B -1.52 B -1.52 B -1.1 B -1.1 B -1.1 B -1.1 B -798 M -798 M -798 M -798 M -483 M -483 M -483 M -483 M -285 M -285 M -285 M -285 M -167 M -167 M -167 M -167 M -113 M -113 M -113 M -113 M -74 M -74 M -74 M - - - - -

Total Assets

1.79 B 773 M 850 M 937 M 1.01 B 1.09 B 1.15 B 1.24 B 1.18 B - 1.34 B 1.44 B 1.54 B 1.87 B 2.49 B 853 M 853 M 853 M 853 M 891 M 891 M 891 M 891 M 858 M 858 M 858 M 858 M 614 M 614 M 614 M 614 M 619 M 619 M 619 M 619 M 420 M 420 M 420 M 420 M 492 M 492 M 492 M 492 M 201 M 201 M 201 M 201 M 137 M 137 M 137 M - - - - -

Cash and Cash Equivalents

254 M 84.5 M 119 M 88.2 M 64.3 M 84.8 M 104 M 139 M 122 M 88.5 M 80 M 203 M 400 M 969 M 1.89 B 127 M 127 M 127 M 127 M 80.9 M 80.9 M 80.9 M 80.9 M 70.5 M 70.5 M 70.5 M 70.5 M 103 M 103 M 103 M 103 M 161 M 161 M 161 M 161 M 71.8 M 71.8 M 71.8 M 71.8 M 14 M 14 M 14 M 14 M 71.6 M 71.6 M 71.6 M 71.6 M 91.3 M 91.3 M 91.3 M - 118 M - - -

Book Value

1.63 B 661 M 744 M 811 M 887 M 964 M 1.04 B 1.1 B 1.05 B - 1.21 B 1.29 B 1.39 B 1.72 B 2.3 B 400 M 400 M 400 M 400 M 641 M 641 M 641 M 641 M 688 M 688 M 688 M 688 M 376 M 376 M 376 M 376 M 359 M 359 M 359 M 619 M 420 M 420 M 420 M 420 M 492 M 492 M 492 M 492 M 201 M 201 M 201 M 201 M 137 M 137 M 137 M - - - - -

Total Shareholders Equity

1.63 B 661 M 744 M 811 M 887 M 964 M 1.04 B 1.1 B 1.05 B 1.12 B 1.21 B 1.29 B 1.39 B 1.72 B 2.3 B 400 M 400 M 400 M 400 M 641 M 641 M 641 M 641 M 688 M 688 M 688 M 688 M 376 M 376 M 376 M 376 M 359 M 359 M 359 M 359 M 345 M 345 M 345 M 345 M 424 M 424 M 424 M 424 M 131 M 131 M 131 M 131 M -72 M -72 M -72 M - -52.8 M - - -

All numbers in USD currency